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The overall health beneficial action of olive oil phenolic components is well established. Recent studies have
elucidated the biological effects of two isolated compounds, namely oleuropein and hydroxytyrosol, with particular
attention on their antioxidant activity. Thus, a protective action has been demonstrated in preclinical studies against
several diseases, especially cardiovascular and metabolic disorders.
The present review will describe the biological effects of oleuropein and hydroxytyrosol, with particular attention
on the molecular mechanism underlying the protective action on cardiovascular and metabolic alterations, as
demonstrated by in vitro and in vivo experimental studies performed with the isolated compounds.
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mellitusIntroduction
Several studies have assigned to the virgin olive oil
(VOO) most of the beneficial effects on human health
attributed to the Mediterranean diet [1-6]. Initially, the
richness of monounsaturated fatty acids (MUFA), and in
particular oleic acid, was considered as the major healthful
characteristic of VOO. Later on, after the observation that
other aliments rich in MUFA, as rapeseeds, soybean and
sunflower, were not comparable with VOO as healthful
food [7,8], the role of some ‘minor components’ has been
taken into consideration, also because such compounds
are able to maintain their biological action when VOO is
consumed in crude form. There are more than 200 ‘minor
components’ in the unsaponifiable fraction of olive oil,
which represent about 2% of the total weight, and include
a number of heterogeneous compounds non-chemically
related to fatty acids (Figure 1) [9,10].* Correspondence: pujia@unicz.it; d.russo@unicz.it
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unless otherwise stated.Particular attention has been focused on the nutraceut-
ical properties of those compounds provided with antioxi-
dant activity. The most abundant antioxidants in VOO
are lipophilic and hydrophilic phenols [11] (Table 1),
which are physiologically produced in the plant to react
against various pathogen attacks and/or insect injuries
[2,12,13]. The antioxidant hydrophilic phenolic alcohols of
VOO and their secondary metabolites also contribute to
the long oil shelf-life and influence several organoleptic
characteristics, including taste (e.g. bitter, astringent,
pungent, throat-catching) and color [14-16].
Nutraceutical properties have been attributed to secoiri-
doid oleuropein (OL) and its derivatives, the main alcohols
3,4-dihydroxyphenyl ethanol, also known as hydroxytyrosol
(HT) and p-hydroxyphenyl ethanol or tyrosol [2,11]
(Figure 2). Such compounds are released from the olive
fruit to VOO during the extraction process. In particular,
OL is abundant in high amounts in unprocessed olive
leaves and fruit, while higher concentration of HT may be
found in the fruit and in olive oil, owing to chemical and
enzymatic reactions that in the plant occur during mat-
uration of the fruit [14,17]. In addition, many agronomicLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Composition of unsaponifiable and saponifiable fractions of olive oil.
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olive fruit and olive trees irrigation, as well as various oil
extraction conditions during crushing, malaxation and
VOO separation, may influence their final concentration
in VOO [18-20].
OL and HT represent the molecules of major interest
for their biological and pharmacological properties, and,
with no doubt, are among the most investigated antioxi-
dant natural compounds [5,11,21]. They have been studied
as isolated compounds or as components of ‘oil phenolic
extracts’, showing a wide variety of beneficial effects,
mainly related to their antioxidant activity (Figure 3), in
many preclinical models of diseases [5,22-26].
In the following sections will be described the bio-
logical effects of OL and HT, as resulting by in vitro
and in vivo experimental data obtained with isolated
compounds.Table 1 The main phenolic compounds in virgin olive oil
Hydrophilic Lipophilic
Phenolic alchols Flavonoids Tocopherols
Hydroxytyrosol Apigenin (α, β, γ, δ)
Tyrosol Luteolin
Secoroidoids Phenolic acids Tocotrienols
Oleuropein Gallic acid (α, β, γ, δ)




Coumaric acidAntioxidant activity of Oleuropein and Hydroxytyrosol
Defense against reactive oxygen species (ROS) is funda-
mental to protect cellular molecules as lipids, proteins or
DNA and avoid the development of degenerative diseases.
When the defensive mechanisms are overtaken by the ac-
tion of the free radicals, the subsequent cellular damage
may lead to several diseases, including atherosclerosis, car-
diovascular diseases, skin and neurodegenerative diseases,
diabetes mellitus and metabolic syndrome. Finally, physio-
logical processes such as aging have been associated with
a disequilibrium between the action of ROS and that of
antioxidants [27,28].
Antioxidant agents are present in various amount in
several types of food. In the VOO, phenolic compounds
in general, and OL derivatives in particular, act as natural
antioxidants. They are important for the food stability and
protect against the oxidation occurring naturally during
VOO storage owing to reaction with air [29].
The antioxidant activity of OL and HT in vivo is related
to their highly bioavailability [23,24]: various studies have
documented a high degree of absorption, fundamental to
exert their metabolic and pharmacokinetics properties
[23,24,30].
OL and HT behave as antioxidant acting as: a. free rad-
ical scavengers and radical chain breaking; b. anti-oxygen
radicals; c. metal chelators. With their catecholic struc-
ture, they are able to scavenge the peroxyl radicals and
break peroxidative chain reactions producing very stable
resonance structures [2,31].
A decrease in ROS production, derived by iron or
copper induced oxidation of low-density lipoproteins
(LDL), was first described after treatment with either
Figure 2 Chemical structure of the best known phenolic compounds in the VOO.
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action on such metals [25,32].
However, a strong free-radical scavenging action has
been demonstrated also by using metal-independent oxi-
dative systems [33] or measuring stable free radicals, such
as 2,2-diphe-1-picrylhydrazyl (DPPH) [34,35]. The ability
to scavenge or reduce the generation of ROS was further
confirmed both in leukocytes treated with phorbol 12-
myristate 13-acetate (PMA) and in hypoxanthine/xanthine
oxidase cell-free system through a chemiluminescence
method [36,37]. Again, a scavenging effect of OL and HT
was demonstrated with respect to hypochlorous acid
(HOCl) [36], a potent oxidant produced in vivo at the
site of inflammation: this activity was demonstrated in a
model of HOCl-mediated inactivation of catalase. This
last evidence may have important implication in the
protection from atherosclerosis, since HOCl can oxidize
the apoproteic component of LDL (see next section).
Zhu et al. have reported that HT induces simultaneously
both phase II detoxifying enzymes (a set of important
enzymes for protecting against oxidative damage) and
mitochondrial biogenesis, two critical pathways occurring
in the fight against oxidative stress [38]. An additional im-
portant element that contributes to the accumulation ofFigure 3 Antioxidant activity and related effects of oleuropein and hyintracellular ROS is the endoplasmic reticulum (ER) stress
[39]: recently, it has been reported that HT is able both to
modulate an adaptive signaling pathway activated after ER
stress and to ameliorate ER homeostasis [40]. It must
be noted that, at higher doses, OL and HT may exert
pro-oxidant activity [41-44], responsible for the anti-
proliferative properties on cancer cells (see Section
“Other activities”).
Protection against cardiovascular diseases
Several studies have emphasized the importance of a
regular use of olive oil in the benefits of traditional
mediterranean diet on cardiovascular diseases [6,45-47].
In particular, beside the antioxidant activity, vasodilatatory,
anti-platelet aggregation and anti-inflammatory effects have
been assigned to olive oil phenolic compounds such as
OL and HT [5,22,23,48].
Several reports have described the protective effects
against atherosclerosis of OL and HT in preclinical experi-
mental models. Visioli et al. [25] have demonstrated that
OL and HT inhibit copper sulphate-induced oxidation of
LDL. As previously mentioned, OL and HT exert a scaven-
ging effect towards HOCl, which acts through chlorination
of apoB-100 as an initiating agent in LDL lipid peroxidationdroxytyrosol.
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atherosclerotic damage. In addition, Jemai et al. demon-
strated that in rats fed with a cholesterol-rich diet, the
same compounds were able to promote hypocholesterole-
mia, lowering LDL plasma levels and total cholesterol;
also, they increased the levels of high-density lipoproteins
(HDL) and the activity of antioxidant enzymes reducing
LDL oxidation [50,51]. Recently, the European Food
Safety Authority (EFSA) has recognized protective effects
of the olive oil phenolic compounds on LDL oxidation, in
particular of HT [52].
Effects other than the reduction of LDL and cholesterol
may explain the anti-atherogenic action of OL and HT,
too (see Table 2). Carluccio et al. described the inhibition
of endothelial activation, an early step in atherogenesis, by
OL and HT, able to reduce lipopolysaccharide (LPS)-
stimulated expression of vascular adhesion molecule-1
(VCAM-1) in human vascular endothelial cells by inhib-
ition of its mRNA levels, thus decreasing monocyte cell
adhesion to endothelial cells [53]. Two additional mecha-
nisms involved in the vascular damages, platelet aggrega-
tion and proliferation of smooth muscle cells, are also
antagonized by the olive oil phenolic compounds. It has
been observed that HT inhibits in vitro platelet aggre-
gation induced by thromboxane B2 production and











(*) myocardial injury induced by ischemia; (**) DXR-induced toxicity; n.d.: not determ
Abbreviations: AMPK 5’-AMP-activated protein kinase; CK Creatine kinase; COX cyclooxy
regulated kinase; GSSG Oxidize glutathione; iNOS inducible nitric oxide synthase; LDL lo
electron transport chain; NO nitric oxide; PDE phosphodiesterase; SOD superoxide dismrats assigned to diet supplemented with HT [55]: in this
study was proposed that both an inhibition of cyclooxy-
genase (COX)-2 with a related decrease of thromboxane
A2 blood levels and an increase of vascular nitric oxide
production may contribute to this effect [55]. Inhib-
ition of vascular smooth muscle cell proliferation has
been demonstrated after treatment with OL, associated
with a reduction of the extracellular regulated kinase-1/2
activity [56].
Some data exist also abut direct cardioprotective effects
of these molecules. Manna et al. [57] analyzed OL effects
in myocardial injury induced by ischemia; in isolated
rat heart perfused with OL before induction of ische-
mia, were measured the levels of creatine kinase, a bio-
chemical marker of cellular damage, and those of
oxidize glutathione, a marker of heart exposure to oxi-
dative stress and a key factor in the pathogenesis of
atherosclerosis. OL significantly decreased levels of
both markers suggesting a cardioprotective effect in
the acute events that follow coronary occlusion. Recently,
it has been observed that OL is able to prevent cardio-
myopathy in rats treated with doxorubicin (DXR) [58].
In addition, Granados et al. have reported that HT
attenuated DXR-associated chronic cardiac toxicity in
rats with breast cancer ameliorating mitochondrial





















genase; DXR doxorubicin; eNOS endothelial nitric oxide synthase; ERK extracellular
w-density lipoproteins; MMP matrix metalloproteinases; METC mitochondrial
utase; VCAM vascular adhesion molecule; VSME vascular smooth muscle cells.
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and hypercholesterolemic rabbits subjected to ischemia
and reperfusion [62]. Treatment with OL for 3 or 6 weeks
considerably reduced the infarct size in normal rabbits
and, at higher doses, in hypercholesterolemic rabbits.
Moreover, OL protection of re-perfused myocardium was
associated with decreased total cholesterol and triglyceride
levels [62].
The cardioprotective effects of HT have been confirmed
in a study conducted with cardiomyocytes extracted from
rats treated with this phenol. In these animals, adminis-
tration of HT reduced the expression of proteins related
to ageing as well as the infarct size and cardiomyocyte
apoptosis [60].
In another study, a reduced infarct size with im-
provement in the myocardial function was shown in
tyrosol-treated rats compared to non-treated controls [61].
Protection against diabetes and metabolic disorders
In the early 90s, Gonzalez et al., using an animal model of
alloxan-induced diabetes mellitus, first postulated a protect-
ive role of OL extracted by olive leaves [63]. Subsequent
studies evidenced a strong link of the antidiabetic action
with the antioxidant effects of OL. By treating alloxan-
diabetic rabbits with OL, Al-Azzawie and Alhamdani ob-
tained a significant hypoglycemic effect as compared with
diabetic control animals, associated with restoration of the
levels of malondialdehyde and most of the enzymatic and
non-enzymatic endogenous antioxidants [64]. Similar data
were reported in alloxan-diabetic rats treated with OL and
HT from olive leaves [65] or using purified HT from olive
mill waste both in vitro and in rats [66].
A close relationship between antioxidant and hypo-
glycemic activity of olive leaf extracts (OLE) was confirmed
by Poudyal et al. [67] in rats with a diet-induced model of
the metabolic syndrome. Supplementation of the diet with
OLE enriched with OL and HT attenuated the metabolic
alterations, including plasma glucose, triglyceride and total
cholesterol concentrations. Such effects were paralleled
by reduced plasmatic malondialdehyde and uric acid
levels, therefore suggesting again a role for the antioxi-
dant activity.
In another animal model of high-fat-diet (HFD)-induced
obesity, hyperglycemia, hyperlipidemia, and insulin resist-
ance, Cao et al. demonstrated the protective effect of HT,
showing its ability to decrease HFD-induced lipid deposits
through inhibition of the SREBP-1c/FAS pathway in liver
and skeletal muscle tissues, enhance antioxidant enzyme
activities, normalize expression of mitochondrial complex
subunits and mitochondrial fission marker Drp1, and
eventually inhibit apoptosis activation [68]. In addition, in
mutant diabetic (db/db) mice, HT significantly decreased
fasting glucose, and lipid serum levels, the latter effects
obtained when treatment with metformin failed. As in theHFD model, muscle mitochondrial carbonyl protein levels
and improved mitochondrial complex activities were also
observed in db/db mice treated with HT [68]. Thus, at
least for HT, the metabolic effects may be not limited to
the action against the oxidative stress [68]. Moreover, in
diabetic rats treated with HT, a reduction of the content
of triglycerides and LDL-cholesterol and an increase of
HDL-cholesterol levels has been reported [26]. Recently,
El et al. suggested that improvement of glucose-induced
insulin release as well as increased peripheral uptake of
glucose are both involved in the hypoglycemic effect of
OL [22].
The effects of OL and HT on insulin action have re-
cently been demonstrated by De Bock et al. in overweight
middle-aged men: administration of a diet supplemented
with olive leaf polyphenols (51.1 mg OL, 9.7 mg HT for
day) determined both amelioration of insulin action and
secretion, two aspects of glucose regulation. Such an effect
was independent of fat distribution, dietary intakes and
physical activity and was comparable to that seen with
drugs used to treat diabetes [69].
Interesting results have come from elucidation of the
gene expression profile performed in the liver of obese
mice treated with OL [70]. In particular, the mRNA levels
of lipocalin 2 (LCN2) (0.33-fold) resulted down-regulated
after OL treatment [70]. Since LCN2 deficiency in mice
has been associated with protection from developing
aging-and obesity-associated insulin resistance and hyper-
glycemia [71], the effect on this protein may represent an
additional target of OL action.
Other activities
OL and HT displayed protective effects against several
other diseases, mainly dependent on their antioxidant
activity. Protection against the genotoxic action of the
ROS is one of the mechanisms explaining the anticancer
effects of these compounds [72-74]. In addition, OL and
HT may act also through the modulation of pro- and
anti-oncogenic signaling pathways, leading to cell apoptosis
and growth arrest of several tumor cell lines in vitro
[73-80]. It has been recently suggested that the anti-
proliferative and pro-apoptotic effects of OL and HT
on tumor cells, may be mediated by their capability to
induce the accumulation of hydrogen peroxide in the
culture medium [41-44].
At present, there are few studies demonstrating the block
of tumor growth in vivo [24,79]. Results from a recent work
by Sepporta et al. [81] demonstrated that OL was able to
inhibit the MCF-7 human breast cells xenograft growth
and their invasiveness into the lung.
Protective properties against infections are attributed
to olive oil extracts or isolated compounds, as confirmed
by many studies reporting anti-microorganisms and anti-
virus activity [82-86].
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erosclerosis, HT, OL and derivatives result effective
also in age-related disorders, as neurodegenerative dis-
eases [48,87,88]. Neuroprotection may derive by inter-
ference with amyloid beta peptide (Aβ) and Tau
protein aggregation [87-90]. Furthermore the potential
neuroprotective effects of HT and OL have also been
reported against brain damages such as brain hypoxia-
reoxygenation, cerebral ischemia and spinal cord injury
[91,92].
At the skin level, HT conjugates with fatty acids showed
optimal topical delivery features through the human
stratum corneum and viable epidermis membranes
[93]. Moreover, co-administration of HT and hydrocor-
tisone in the co-loaded nanoparticles provide addi-
tional anti-inflammatory and antioxidant benefits
in atopic dermatitis treatment [94]. OL intra-dermalTable 3 Effects of oleuropein and hydroxytyrosol in neoplast
Protection Model Effect
Cancer Bladder cancer cells ↓cell prolifer





Colon cancer cells ↓cell prolifer
↑apoptosis
↓motility an
Glia cancer cells ↓motility




Prostate cancer cells ↓cell prolifer
↑apoptosis
Renal cancer cells ↓cell prolifer
Thyroid cancer cells cell cycle arr
↑apoptosis
Mice xenograft and albino
hairless HOS:HR-mice
↓tumor grow
Neurodegenerative disease Brain hypoxia-reoxygenation antioxidant
In vitro assay ↓Tau aggreg
Sprague–Dawley rats ↓spinal cord
Skin disease Albino hairless HOS:HR and
C57BL/6J mice
↑UVB protec
Balb/c mice ↑wound hea
Abbreviations: AKT serine/threonine-specific protein kinase; CDK cyclin-dependent p
hydrogen peroxide; ERK extracellular regulated kinase; IL1β interleukin 1β; MDA ma
superoxide ions; Pin1 peptidyl-prolyl cis–trans isomerase; PGE2 prostaglandin E2; VEinjection also reduced cell infiltration in the wound
site and forwards collagen fibers deposition and more ad-
vanced re-epithelialization in vivo [95].
Finally, OL has demonstrated beneficial antioxidant
properties even against ethanol-induced gastric damages
in vivo [96].
Table 3 summarizes the main results regarding the
effects of isolated OL and HT in preclinical models of
neoplastic, neurodegenerative and skin diseases.
Conclusions and remarks
The large number of preclinical studies described herein
has revealed the molecular basis of the beneficial actions
of single components of the phenolic fraction of olive oil.
Although some of these effects may derive from the
interaction of the various VOO components generated
by enzymatic hydrolysis of the phenolic extracts whenic, neurodegenerative and skin diseases
Mechanism References
ation n.d. [75]













est ↓pAKT, ↓pERK [80]
th ↓COX-2, ↓VEGF, ↓MMP-2/9/13 [81,98]




injury ↓MDA activity [91]
tion ↓MMP-13 [98,99]
ling ↑VEGF [95]
rotein kinase; c-jun transcription factor member; COX-2 cyclooxygenase-2; H2O2
londialdehyde; MMP-2/9/13 matrix metalloproteinase; NO nitric oxide; O2
GF vascular endothelial growth factor; n.d. not determined.
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candidates for a pharmacological use, both as single
drug or after enrichment of olive oil or other food com-
ponents. Moreover, OL and HT possess high bioavail-
ability [23,24], together with an absolute absence of
either acute or sub-chronic toxicity, at least as shown in
animal experimental models [100,101]. In view of a
possible use of OL and HT in human pathology, more
than one approach is under investigation. The high stabil-
ity and bioavailability of these compounds has encouraged
attempts to enrich the olive oil or other food components
with isolated/purified phenolic compounds [102,103].
In addition, implementation of the preparation process
by the food industry and modification of the molecules to
obtain more active derivatives are also promising strategies.
Noteworthy, recent results obtained with OL aglycone or
some semisynthetic derivatives [80,97,102,104-107] suggest
that it is possible to improve the pharmacological proper-
ties of these compounds. Further studies will better clarify
the in vivo effects of OL, HTand their semisynthetic deriva-
tives, to use as individual agents or in combination, with
particular attention to their safety profile on humans, and
open the way to a wide utilization in human pharmacology.
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